Skip to content

Second patient death reported with gene therapy for muscular dystrophy

Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported the death.

FILE – The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed, Oct. 14, 2015. (AP Photo/Andrew Harnik, File)
FILE – The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed, Oct. 14, 2015. (AP Photo/Andrew Harnik, File)
Author
UPDATED:

Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported the death.

Subscribe to continue reading this article.

Already subscribed? To log in, click here.

Originally Published:

RevContent Feed

Page was generated in 3.1267659664154